King licenses Aventis products
King Pharmaceuticals (acquires and sells branded pharmaceuticals) licensed exclusive US (including Puerto Rico) and Canadian rights from Aventis to two marketed asthma products, Intal (cromolyn sodium) and Tilade (nedocromil sodium), and exclusive global rights outside of Japan to Synercid (dalfopristin, quinupristin), for €189.9mm ($199mm) in cash.
- Specialty Pharmaceuticals
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com